| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-40 |
| filingDate |
1977-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1980-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fea269c7327a162f9751c2030533841 |
| publicationDate |
1980-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4201866-A |
| titleOfInvention |
O-Hemi-succinate of propranolol |
| abstract |
This invention is directed to novel compounds having β-adrenergic blocking activity. The compounds are represented by the following structural formula: ##STR1## wherein R 1 is hydrogen or methyl, R 2 is hydrogen or lower alkyl and their pharmaceutically acceptable salts. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3589327-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016271157-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11420995-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4734500-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2678652-B2 |
| priorityDate |
1977-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |